Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Our AI scores Asp Isotopes Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Asp Isotopes Inc. is a small-cap company with a market capitalization of $318M. It ranks number 5 by market capitalization among the 9 Miscellaneous Chemical Products issuers in our coverage with a current forecast. Its Current Ratio of 3.87x is the highest of the 8 peers that report one.
For ASPI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 2.0%, measured on 339 forecast dates between 2022-12-23 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 11.0%, measured on 382 forecast dates between 2022-12-23 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, ASPI included.
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Miscellaneous Chemical Products peers listed below that report each metric.
| Metric | ASPI | Rank |
|---|---|---|
| Market Cap | $318M | 5/9 |
| P/B Ratio | 1.20x | 6/8 |
| EPS | $-1.39 | – |
| Book Value/Share | $1.73 | – |
| Metric | ASPI | Rank |
|---|---|---|
| ROIC | -17.1% | 7/8 |
| Gross Margin | 21.7% | 8/9 |
| Operating Margin | -450.8% | 9/9 |
| EBT Margin | -779.3% | 9/9 |
| Tax Rate | -0.0% | – |
| Metric | ASPI | Rank |
|---|---|---|
| Current Ratio | 3.87x | 1/8 |
| Quick Ratio | 3.85x | 1/8 |
| D/E Ratio | 1.12x | 4/8 |
| Financial Leverage | 2.16x | 4/8 |
| Interest Coverage | -18.7x | 7/8 |
| Working Capital | $202M | 3/8 |
| Metric | ASPI | Rank |
|---|---|---|
| Operating Cash Flow | -$76M | 9/9 |
| Metric | ASPI | Rank |
|---|---|---|
| Inventory Turnover | 7.4x | 2/8 |
| Days Inventory | 50 days | 7/8 |
| Payables Period | 185 days | 2/8 |
| Metric | ASPI | Rank |
|---|---|---|
| Operating Income | -$86M | 9/9 |
| R&D Expense | $16M | 4/8 |
| Cost of Goods Sold | $11M | 8/9 |
| Metric | ASPI | Rank |
|---|---|---|
| Shares Outstanding | 153M | – |
| Total Current Assets | $272M | 47.6% of assets |
| Cash & Short-term Investments | $220M | 38.4% of assets |
| Accounts Receivable | $3M | 0.5% of assets |
| Inventory | $2M | 0.3% of assets |
| Total Liabilities | $297M | 52.0% of assets |
| Short-term Debt | $65M | 11.3% of assets |
Companies classified under the same SEC industry code as Asp Isotopes Inc. (Miscellaneous Chemical Products): 9 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| ASPI Asp Isotopes Inc. | $318M | |
| ESI Element Solutions Inc | $7.46B | |
| CBT Cabot Corp | $3.67B | |
| WDFC Wd 40 Co | $2.97B | |
| FTK Flotek Industries Inc/Cn/ | $886M | |
| OEC Orion S.A. | $224M | |
| ARQ Arq, Inc. | $105M | |
| FSI Flexible Solutions International Inc | $78M | |
| PURE Pure Bioscience, Inc. | $9M |
Phase 1 plant now in stable operation following commissioning; first liquid helium in storage ahead of initial deliveries to contracted offtakersDALLAS, Oct. 26, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes ...
Tetra4, a subsidiary of Renergen and the developer of the Virginia Gas Project, has started the commissioning phase of the Phase 1 Liquid Helium plant post engineering optimization The production is ...
Good day, and welcome to the ASP Isotopes business update call. Please note this event is being recorded. I would now like to turn the conference over to Shveta Dighe, Head of Investor Relations.
Our AI scores Asp Isotopes Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
For ASPI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 2.0%, measured on 339 forecast dates between 2022-12-23 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 11.0%, measured on 382 forecast dates between 2022-12-23 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Asp Isotopes Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
9 issuers in our coverage, ASPI included, share the SEC industry code Miscellaneous Chemical Products. The largest are: Element Solutions Inc (ESI), Cabot Corp (CBT), Wd 40 Co (WDFC), Flotek Industries Inc/Cn/ (FTK), Orion S.A. (OEC), Arq, Inc. (ARQ).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.
